Nathan Treff

[Nathan Treff @TreffDNA]

@BortzGroup @nucleusgenomics @carlzimmer @nytimes @EgliDieter @Columbia It’s currently under review

[Nathan Treff @TreffDNA]

https://t.co/PXwsR6FL5m

[Nathan Treff @TreffDNA]

Can't believe it's been a year since Nucleus Embryo launched. Seeing patients become more confident during their IVF journey has been the most rewarding part of building this.

[Nucleus Genomics @nucleusgenomics]

One year ago, we launched Nucleus Embryo — the most advanced embryo analysis available.

Our belief was simple: one of the most important decisions of your life deserves to be made with all the information modern science has to offer.

In the year since launch, Nucleus Embryo has become one of the fastest-adopted technologies in modern fertility care. It's now available in IVF clinics across almost every U.S. state and more than 165 clinics globally.

Find out why more parents are choosing Nucleus Embryo below.

[Nathan Treff @TreffDNA]

Best part of the job is seeing our research being transformed into something that's helping couples build families.

[Nucleus Genomics @nucleusgenomics]

During family planning, many health decisions are reactive. A cheek swab before pregnancy can change that.

Here’s what the process looks like for Nucleus Preview, our comprehensive carrier screening.

[Nathan Treff @TreffDNA]

Seems like decades ago when we demonstrated that blastomere biopsy was not the way to go. Reproductive medicine has come so far!

[Kian Sadeghi @KianSadeghi5]

Nathan, our Chief Clinical Officer, is a leader in reproductive research.

In fact, one of his papers changed the entire IVF industry, showing a far more effective way to biopsy an embryo.

Rigorous science has always guided advanced embryo testing.

[Nathan Treff @TreffDNA]

Back when I thought ivf babies would benefit from having a cryopreserved genetically matched embryonic stem cell line and taqman assays were new . NJ commission on science and technology grant application denied :) https://t.co/cxFV3b1ffr